• About
  • Partnerships
  • Challenges
  • Awards
  • Grant Opportunities
  • News

GP63-Targeted Conjugate for Photodynamic Therapy of Visceral Leishmaniasis

Tayyaba Hasan of Harvard University in the U.S. will work to design a conjugate which will attach to the GP63 enzyme of the Leishmania parasite. This therapy will consist of a lightactivatable, non-toxic chemical that will be activated by a light source, killing the parasite but leaving surrounding cells intact.

More information about Create Drugs and Delivery Systems to Limit Drug Resistance (Round 1)

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

The Bill & Melinda Gates Foundation is part of the Grand Challenges partnership network. Visit www.grandchallenges.org to view the map of awarded grants across this network and grant opportunities from partners.